BCG July 18, 2024
Headquartered in Cambridge, Massachusetts, Biogen is a global biotechnology company that has pioneered innovative therapies for multiple sclerosis, spinal muscular dystrophy, and Alzheimer’s disease. Chief Financial Officer Mike McDonnell sat down with BCG’s Torben Danger to discuss Fit for Growth, the company’s bold transformation initiative, and employees’ role in making it a success. The discussion also touched on leadership, inorganic growth, and AI. Edited excerpts of the conversation follow.
Biogen CFO Mike McDonnell on the leadership lessons he learned from his roles across different industries.